3,0
23. Feb. 2023
Aktueller Mitarbeiter, mehr als 1 Jahr
Berlin
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good pay, flexible working time, good social engagement iniciatives
Kontras
Many overloaded with work, too many systems, too many stakeholders, making clinical trials execution even more complex and inefficient. Too many changes (new come before the recent ones have been established properly) and big rotation of staff in projects.